New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
08:25 EDTABBV, ABBV, AET, AET, AMGN, AMGN, ESRX, ESRX, HSP, HSP, MNTA, MNTA, PFE, PFEFTC to hold a workshop
The Biologics Workshop explores competition issues involving biologic medicines and follow-on biologics with a focus on the potential impact of state regulations affecting competition. Companies participating include AbbVie, Aetna, Amgen, Express Scripts, Hospira, Momenta Pharmaceuticals and Pfizer at the FTC Washington, D.C. offices on February 4 at 8:30 am. Webcast Link
News For ABBV;AET;AMGN;ESRX;HSP;MNTA;PFE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
June 23, 2015
07:44 EDTAETHumana takeover looks unlikely below $210/share, says Leerink
Subscribe for More Information
07:25 EDTPFE, AMGNPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
June 22, 2015
18:56 EDTAETCigna/Anthem deal could leave Humana with Aetna as only suitor, Bloomberg says
Subscribe for More Information
08:52 EDTPFEPortola, Bristol-Myers, and Pfizer announce results from Phase 3 ANNEXA study
Subscribe for More Information
08:16 EDTAET, ESRXAnthem, Cigna deal would be negative for Catamaran, says Leerink
Subscribe for More Information
07:54 EDTAETAnthem, Cigna deal likely to be consummated, says Leerink
Subscribe for More Information
07:16 EDTAETAnthem should be bought after Cigna offer, says Stifel
After Anthem, (ANTM) offered to buy Cigna (CI) and the latter company rejected the bid, Stifel estimates that the deal would have been 10% accretive for Anthem in the first year and 20% accretive in the second year. The firm thinks that accretion from the deal will probably be higher than expected. It also recommends buying Aetna (AET) as it believes that the Anthem offer suggests that Aetna will benefit more than expected from its own deal. The firm is cautious on Humana (HUM), saying that it may lose two potential buyers in Anthem and Cigna, while Humana may retreat if Aetna does not acquire the company quickly.
07:01 EDTPFEPfizer to acquire Nimenrix, Mencevax from GlaxoSmithKline for $130M
Pfizer (PFE) announced that it has entered into an agreement with GlaxoSmithKline (GSK) to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for a total consideration of approximately $130M. This transaction will add two high-quality and complementary vaccines to Pfizer’s portfolio, allowing the company to reach a broader global population. Nimenrix is a single dose meningococcal ACWY-TT conjugated vaccine designed to protect against Neisseria meningitidis, an uncommon but highly contagious disease that can lead to disability and death. Mencevax is a single-dose meningococcal ACWY unconjugated polysaccharide vaccine used to control outbreaks of meningococcal infection and for travelers to countries where the disease is endemic or highly epidemic. Pfizer does not expect this transaction to have any significant impact on its 2015 financial performance. The transaction is subject to customary closing conditions as well as regulatory approvals in several markets, and is expected to occur in the second half of 2015. Pfizer’s legal advisors for the transaction were Ropes & Gray and Clifford Chance.
06:51 EDTAETHealth insurer tie-ups could cut competition, WSJ reports
Subscribe for More Information
06:37 EDTAETHealth insurers may change policies based on King v. Burwell ruling, NYT says
Subscribe for More Information
June 21, 2015
16:03 EDTAETAetna makes offer to acquire Humana, WSJ says
Subscribe for More Information
June 19, 2015
16:24 EDTAETStocks end week higher after Fed reassures on gradual pace of rate increases
Subscribe for More Information
16:02 EDTAMGNAmgen presents open-label extension data for Phase 2 study of migraine treatment
Subscribe for More Information
14:07 EDTAETOptions with increasing implied volatility: NFLX CI TRIP AET
11:17 EDTESRXExpress Scripts calls active amid bid speculation
Subscribe for More Information
10:09 EDTAETFly Watch: Supreme Court may release key ACA decision soon
Subscribe for More Information
09:18 EDTAETHumana most likely target in Managed Care, says FBR Capital
FBR Capital says Humana (HUM) is the most likely acquisition target in the Managed Care space, with Aetna (AET), Anthem (ANTM) and Cigna (CI) as the likely acquirers. The firm believes Anthem would benefit the most from the acquisition of Humana. It also thinks UnitedHealth (UNH) could look to acquire Aetna or Cigna. FBR thinks one or two more large deals in the space are possible.
07:37 EDTAETSupreme Court decision on ACA suit due soon, says UBS
Subscribe for More Information
07:23 EDTAMGNTeva data quite strong, says Bernstein
After Teva (TEVA) announced data for its TEV-48125 drug in episodic migraine, Bernstein notes that the drug met its primary and secondary endpoints. The firm says that the reduction in migraine days of Teva's drug appears to be higher than what Amgen (AMGN) and Lilly (LLY) have shown. The firm continues to see the migraine treatments from Teva and Alder as better than those from Lilly and Amgen.
07:17 EDTMNTAMomenta price target raised to $31 from $25 at Brean Capital
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use